Simplex Trading, LLC Galera Therapeutics, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$0.09 - $0.27 $504 - $1,514	-5,610 Reduced 93.48%	391 $0
Q3 2023 Nov 01, 2023	SELL	$0.17 - $3.0 $253 - $4,473	-1,491 Reduced 19.9%	6,001 $1,000
Q2 2023 Aug 04, 2023	BUY	$2.5 - $3.42 $18,730 - $25,622	7,492 New	7,492 $23,000
Q4 2022 Feb 02, 2023	BUY	$1.34 - $1.78 $46,874 - $62,266	34,981 New	34,981 $52,000
Q2 2022 Aug 03, 2022	SELL	$1.24 - $2.39 $20,874 - $40,233	-16,834 Reduced 90.69%	1,729 $2,000
Q1 2022 May 02, 2022	SELL	$2.01 - $4.19 $180,228 - $375,700	-89,666 Reduced 82.85%	18,563 $44,000
Q4 2021 Feb 23, 2022	BUY	$1.27 - $8.28 $137,450 - $896,136	108,229 New	108,229 $496,000

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.